Article Text

other Versions

PDF
Natural killer cells and hepatitis C: action and reaction
  1. Kuldeep Cheent,
  2. Salim I Khakoo
  1. Division of Medicine, Imperial College London, London, UK
  1. Correspondence to Salim I Khakoo, 10th Floor QEQM Building, Imperial College, St Mary's Campus, South Wharf Road, London W2 1NS, UK; skhakoo{at}imperial.ac.uk

Abstract

In 1989, hepatitis C virus (HCV) was first identified as the infectious agent responsible for human non-A, non-B hepatitis.1 Two decades later, HCV remains a global public health problem with a suboptimal response rate to treatment and the absence of a protective vaccine. Recent work has highlighted the influence of the innate immune system, and in particular natural killer cells, on the outcome and pathology of HCV infection. These cells are considerably more complex than was originally thought and their role in viral infections is currently being unravelled. This review summarises our emerging understanding of natural killer cells in HCV infection.

  • Hepatitis C
  • natural killer cells
  • cytokines
  • MHC
  • cytokines
  • immunogenetics
  • immunology in hepatology

Statistics from Altmetric.com

Footnotes

  • Funding KC and SIK are supported by The Wellcome Trust

  • Competing interests None to declare.

  • Provenance and peer review Commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.